Pembrolizumab for Early Triple-Negative Breast Cancer. Reply. Schmid P, Dent R, O'Shaughnessy J. N Engl J Med 2020;382:e108.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schmid P, Dent R, O'Shaughnessy J. Pembrolizumab for Early Triple-Negative Breast Cancer. Reply. N Engl J Med 2020;382:e108.
PMID: 32579835